Bain Capital Life Sciences Opportunities III, LP - 30 Sep 2025 SCHEDULE 13G/A Report for CENTURY THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (IPSC)

Filing Manager
Bain Capital Life Sciences Opportunities III, LP
Reporting Manager
Bain Capital Life Sciences Opportunities III, LP
Security
CENTURY THERAPEUTICS, INC. Common Stock, $0.0001 par value per share
Symbol
IPSC
Shares outstanding
86,307,537 shares
Disclosed Ownership
3,538,609 shares
Ownership
4.1%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 16:30:02 UTC
Date of event
30 Sep 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Bain Capital Life Sciences Opportunities III, LP disclosed 4.1% ownership in CENTURY THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (IPSC) on 30 Sep 2025."

Quick Takeaways

  • Bain Capital Life Sciences Opportunities III, LP filed SCHEDULE 13G/A for CENTURY THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (IPSC).
  • Disclosed ownership: 4.1%.
  • Date of event: 30 Sep 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Nov 2025, 16:30.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Bain Capital Life Sciences Opportunities III, LP 4.1% 3,538,609 0 3,538,609 /s/ Ricky Sun Ricky Sun, Partner of Bain Capital Life Sciences Investors, LLC

Sponsored